Meta Platforms
META
Tesla
TSLA
NVIDIA
NVDA
Alphabet-A
GOOGL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
URGN UroGen Pharma Ltd
- 10.715
- +0.075+0.70%
Trading Dec 23 09:30 ET
452.17MMarket Cap-3.55P/E (TTM)
10.715High10.580Low4.47KVolume10.640Open10.640Pre Close47.52KTurnover0.01%Turnover RatioLossP/E (Static)42.20MShares20.70052wk High17.71P/B346.61MFloat Cap10.51052wk Low--Dividend TTM32.35MShs Float69.568Historical High--Div YieldTTM1.27%Amplitude4.850Historical Low10.640Avg Price1Lot Size
UroGen Pharma Ltd Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 69.30%249.58M | 409.67%241.08M | 152.17%164.05M | 37.02%136.97M | 37.02%136.97M | 53.70%147.42M | -57.67%47.3M | -52.32%65.05M | 12.14%99.96M | 12.14%99.96M |
| -Cash and cash equivalents | 4.70%124.92M | 992.92%219.97M | 259.71%131.44M | 71.46%95M | 71.46%95M | 315.90%119.31M | -75.06%20.13M | -65.33%36.54M | 24.91%55.41M | 24.91%55.41M |
| -Short-term investments | 343.41%124.66M | -22.33%21.11M | 14.35%32.61M | -5.81%41.97M | -5.81%41.97M | -58.18%28.11M | -12.48%27.17M | -8.21%28.51M | -0.50%44.56M | -0.50%44.56M |
| Receivables | 77.49%22.8M | 12.32%17.42M | 13.33%14.16M | 21.56%15.44M | 21.56%15.44M | 36.25%12.85M | 33.72%15.51M | 31.52%12.49M | 8.42%12.7M | 8.42%12.7M |
| -Accounts receivable | 77.49%22.8M | 12.32%17.42M | 13.33%14.16M | 21.56%15.44M | 21.56%15.44M | 36.25%12.85M | 33.72%15.51M | 31.52%12.49M | 8.42%12.7M | 8.42%12.7M |
| Inventory | 51.82%7.59M | 49.20%7.44M | 32.51%7.24M | 31.17%5.67M | 31.17%5.67M | 2.88%5M | -1.17%4.99M | 14.93%5.47M | -10.49%4.33M | -10.49%4.33M |
| Restricted cash | 31.33%1.07M | 1.10%825K | 1.11%823K | 0.98%821K | 0.98%821K | 0.62%817K | 0.62%816K | 48.00%814K | -33.69%813K | -33.69%813K |
| Other current assets | -12.38%14.05M | -4.05%12.21M | -13.63%10.49M | -7.39%10.28M | -7.39%10.28M | 51.59%16.04M | 21.95%12.72M | 30.95%12.15M | 48.49%11.1M | 48.49%11.1M |
| Total current assets | 62.03%295.1M | 242.99%278.97M | 105.02%196.76M | 31.25%169.19M | 31.25%169.19M | 49.78%182.12M | -41.75%81.33M | -40.21%95.97M | 12.69%128.91M | 12.69%128.91M |
| Non current assets | ||||||||||
| Net PPE | -39.15%1.66M | -39.34%1.83M | -41.46%2.01M | -37.05%2.36M | -37.05%2.36M | -34.81%2.73M | -18.92%3.02M | 26.08%3.43M | 19.13%3.75M | 19.13%3.75M |
| -Gross PPE | -9.51%5.87M | -9.36%5.98M | -10.52%6.08M | -8.51%6.31M | -8.51%6.31M | -8.58%6.49M | 3.06%6.59M | 31.69%6.8M | 28.40%6.9M | 28.40%6.9M |
| -Accumulated depreciation | -11.99%-4.21M | -15.94%-4.15M | -21.03%-4.08M | -25.46%-3.95M | -25.46%-3.95M | -29.10%-3.76M | -33.64%-3.58M | -37.94%-3.37M | -41.51%-3.15M | -41.51%-3.15M |
| Investments and advances | -28.68%4.64M | -97.45%203K | -95.27%481K | --4.5M | --4.5M | --6.51M | 1,084.25%7.97M | 1,408.16%10.17M | --0 | --0 |
| Other non current assets | -76.04%545K | -72.11%848K | -60.87%1.32M | -23.62%2.26M | -23.62%2.26M | -15.55%2.28M | 43.24%3.04M | 88.52%3.38M | 93.16%2.96M | 93.16%2.96M |
| Total non current assets | -40.52%6.85M | -79.46%2.88M | -77.54%3.81M | 35.95%9.13M | 35.95%9.13M | 67.32%11.51M | 115.25%14.03M | 227.12%16.98M | 25.32%6.71M | 25.32%6.71M |
| Total assets | 55.94%301.94M | 195.56%281.85M | 77.57%200.57M | 31.48%178.31M | 31.48%178.31M | 50.72%193.63M | -34.75%95.36M | -31.84%112.95M | 13.26%135.62M | 13.26%135.62M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 37.49%5.56M | 78.51%8.32M | -10.18%6.26M | 17.86%6.51M | 17.86%6.51M | 58.78%4.04M | 89.62%4.66M | 64.57%6.97M | -4.48%5.53M | -4.48%5.53M |
| -accounts payable | 37.49%5.56M | 78.51%8.32M | -10.18%6.26M | 17.86%6.51M | 17.86%6.51M | 58.78%4.04M | 89.62%4.66M | 64.57%6.97M | -4.48%5.53M | -4.48%5.53M |
| Current accrued expenses | 40.70%14.13M | 31.45%15.44M | 17.09%11.9M | 46.21%10.02M | 46.21%10.02M | 47.44%10.04M | 89.73%11.74M | 78.22%10.16M | 8.55%6.86M | 8.55%6.86M |
| Other current liabilities | 14.64%4.07M | -0.58%3.62M | 0.38%3.2M | 17.83%3.86M | 17.83%3.86M | 17.73%3.55M | 22.80%3.64M | -20.55%3.19M | -1.62%3.28M | -1.62%3.28M |
| Current liabilities | 27.14%32.79M | 27.86%34.22M | 4.38%26.34M | 30.51%31.21M | 30.51%31.21M | 35.73%25.79M | 48.36%26.77M | 32.18%25.23M | 6.86%23.92M | 6.86%23.92M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 22.48%121.92M | -1.27%98.24M | -1.12%98.23M | 0.27%99.4M | 0.27%99.4M | 35.02%99.54M | 36.85%99.51M | 39.78%99.34M | 24,805.28%99.12M | 24,805.28%99.12M |
| -Long term debt | 23.54%121.71M | -0.49%97.81M | -0.36%97.59M | 1.04%98.55M | 1.04%98.55M | 37.08%98.52M | 38.06%98.3M | 38.34%97.94M | --97.54M | --97.54M |
| -Long term capital lease obligation | -79.34%212K | -64.85%425K | -54.60%637K | -46.78%844K | -46.78%844K | -44.72%1.03M | -20.20%1.21M | 406.50%1.4M | 298.49%1.59M | 298.49%1.59M |
| Derivative product liabilities | 10.49%118.53M | 10.88%115.88M | 10.83%112.95M | 10.92%109.72M | 10.92%109.72M | 11.52%107.28M | 11.82%104.51M | 13.51%101.91M | 15.41%98.92M | 15.41%98.92M |
| Total non current liabilities | 16.11%243.64M | 4.97%217.31M | 4.94%214.37M | 5.59%212.31M | 5.59%212.31M | 21.46%209.84M | 22.49%207.03M | 24.79%204.27M | 126.03%201.06M | 126.03%201.06M |
| Total liabilities | 17.32%276.43M | 7.59%251.54M | 4.88%240.71M | 8.24%243.52M | 8.24%243.52M | 22.88%235.63M | 24.99%233.8M | 25.56%229.51M | 102.08%224.98M | 102.08%224.98M |
| Shareholders'equity | ||||||||||
| Share capital | 36.90%115K | 75.00%112K | 54.69%99K | 41.27%89K | 41.27%89K | 33.33%84K | 3.23%64K | 3.23%64K | 3.28%63K | 3.28%63K |
| -common stock | 36.90%115K | 75.00%112K | 54.69%99K | 41.27%89K | 41.27%89K | 33.33%84K | 3.23%64K | 3.23%64K | 3.28%63K | 3.28%63K |
| Retained earnings | -17.66%-768.71M | -17.99%-745.04M | -17.18%-711.63M | -17.72%-679.35M | -17.72%-679.35M | -19.17%-653.33M | -20.87%-631.45M | -22.51%-607.32M | -23.49%-577.1M | -23.49%-577.1M |
| Paid-in capital | 29.85%793.87M | 57.22%775.27M | 36.82%671.44M | 25.88%614.04M | 25.88%614.04M | 26.05%611.39M | 2.41%493.11M | 2.53%490.74M | 2.54%487.79M | 2.54%487.79M |
| Gains losses not affecting retained earnings | 276.12%236K | 79.87%-31K | 17.78%-37K | 111.21%12K | 111.21%12K | 13.55%-134K | -175.00%-154K | 34.78%-45K | -328.00%-107K | -328.00%-107K |
| Total stockholders'equity | 160.76%25.52M | 121.90%30.31M | 65.57%-40.13M | 27.02%-65.21M | 27.02%-65.21M | 33.65%-41.99M | -238.36%-138.43M | -582.64%-116.55M | -1,162.18%-89.36M | -1,162.18%-89.36M |
| Total equity | 160.76%25.52M | 121.90%30.31M | 65.57%-40.13M | 27.02%-65.21M | 27.02%-65.21M | 33.65%-41.99M | -238.36%-138.43M | -582.64%-116.55M | -1,162.18%-89.36M | -1,162.18%-89.36M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.